Home

márketing paridad Contratación 4t1 mouse model impresión Excavación exageración

Combination of local, nonviral IL12 gene therapy and systemic paclitaxel  treatment in a metastatic breast cancer model: Molecular Therapy
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model: Molecular Therapy

Shikonin induces an anti‑tumor effect on murine mammary cancer via  p38‑dependent apoptosis
Shikonin induces an anti‑tumor effect on murine mammary cancer via p38‑dependent apoptosis

Primary tumor-induced immunity eradicates disseminated tumor cells in  syngeneic mouse model | Nature Communications
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications

Frontiers | Multi-Omics Characterization of the 4T1 Murine Mammary Gland  Tumor Model
Frontiers | Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model

Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals  Effects of the Epithelial Microenvironment on Tumor Progression and  Metastasis | Anticancer Research
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research

Molecules | Free Full-Text | In Vivo Anti-Tumor Effects of Citral on 4T1  Breast Cancer Cells via Induction of Apoptosis and Downregulation of  Aldehyde Dehydrogenase Activity
Molecules | Free Full-Text | In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity

New In Vivo Syngeneic Mammary Fat Pad Mouse Model Shuttle Session - by  Explicyte Immuno-Oncology
New In Vivo Syngeneic Mammary Fat Pad Mouse Model Shuttle Session - by Explicyte Immuno-Oncology

Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic  Proteins in a 4T1 Murine Breast Cancer Model | PLOS ONE
Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model | PLOS ONE

4T1 Syngeneic Murine Model - Altogen Labs
4T1 Syngeneic Murine Model - Altogen Labs

In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology

In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology

Epithelial-type systemic breast carcinoma cells with a restricted  mesenchymal transition are a major source of metastasis | Science Advances
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis | Science Advances

Imagable 4T1 model for the study of late stage breast cancer | BMC Cancer |  Full Text
Imagable 4T1 model for the study of late stage breast cancer | BMC Cancer | Full Text

Breast cancer mouse model. (A) Murine breast cancer model established... |  Download Scientific Diagram
Breast cancer mouse model. (A) Murine breast cancer model established... | Download Scientific Diagram

BH is effective in TNBC tumor model. On day 8, 4T1 tumor model mice... |  Download Scientific Diagram
BH is effective in TNBC tumor model. On day 8, 4T1 tumor model mice... | Download Scientific Diagram

In-vivo antitumor activity of compound 19 in a syngeneic (4T1 induced)... |  Download Scientific Diagram
In-vivo antitumor activity of compound 19 in a syngeneic (4T1 induced)... | Download Scientific Diagram

Plasmodium infection inhibits triple negative 4T1 breast cancer potentially  through induction of CD8+ T cell-mediated antitumor responses in mice -  ScienceDirect
Plasmodium infection inhibits triple negative 4T1 breast cancer potentially through induction of CD8+ T cell-mediated antitumor responses in mice - ScienceDirect

Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the  Immune Response Induced in an Immunocompetent Mouse Model - Paola Lasso,  Mónica Llano Murcia, Tito Alejandro Sandoval, Claudia Urueña, Alfonso
Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the Immune Response Induced in an Immunocompetent Mouse Model - Paola Lasso, Mónica Llano Murcia, Tito Alejandro Sandoval, Claudia Urueña, Alfonso

Comparison of breast cancer metastasis models reveals a possible mechanism  of tumor aggressiveness | Cell Death & Disease
Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness | Cell Death & Disease

Frontiers | 4T1 Mammary Carcinoma Colonization of Metastatic Niches Is  Accelerated by Obesity
Frontiers | 4T1 Mammary Carcinoma Colonization of Metastatic Niches Is Accelerated by Obesity

Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in  Combination With Immune Stimulation: Molecular Therapy
Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune Stimulation: Molecular Therapy